Article Information
PMID
Published By
Print ISSN
0258-851X
Online ISSN
1791-7549
History
- Received May 3, 2022
- Revision received May 13, 2022
- Accepted May 16, 2022
- Published online June 23, 2022.
Copyright & License
Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- DANIEL H. ALBERT1⇑,
- NEAL C. GOODWIN2,
- ANGELA M. DAVIES2,
- JENNY ROWE3,
- GEROLD FEUER3,
- MICHAEL BOYIADZIS4,
- KATHLEEN A. DORRITIE4,
- MARIA MANCINI2,
- REGINA GANDOUR-EDWARDS5,
- BRIAN A. JONAS6,
- GAUTAM BORTHAKUR7,
- IBRAHIM ALDOSS8,
- DAVID A. RIZZIERI9,
- OLATOYOSI ODENIKE10,
- THOMAS PREBET11,
- SANJANA SINGH1,
- RELJA POPOVIC1,
- YU SHEN1,
- KEITH F. MCDANIEL1,
- WARREN M. KATI1,
- DIMPLE A. MODI1,
- MONICA MOTWANI1,
- JOHANNES E. WOLFF1 and
- DAVID J. FROST1
- 1AbbVie, Inc., North Chicago, IL, U.S.A.;
- 2Champions Oncology, Inc., Hackensack, NJ, U.S.A.;
- 3HuMurine Technologies, La Verne, CA, U.S.A.;
- 4University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, U.S.A.;
- 5Department of Pathology & Laboratory Medicine, UC Davis School of Medicine, Sacramento, CA, U.S.A.;
- 6University of California Davis School of Medicine, Sacramento, CA, U.S.A.;
- 7Department of Leukemia, The University of Texas MD Anderson, Houston, TX, U.S.A.;
- 8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, U.S.A.;
- 9Medical Oncology, Novant Health Cancer Institute, Charlotte, NC, U.S.A.;
- 10Section of Hematology/Oncology, The University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, U.S.A.;
- 11Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, U.S.A.
- Correspondence to: Daniel H. Albert, Dept. R4N2, Bldg. AP3, Rm. 316, 1 North Waukegan Road, North Chicago, IL 60064-6098, U.S.A. Tel: +1 8479373844, Fax: +1 8479383266, e-mail: daniel.h.albert{at}abbvie.com
